Literature DB >> 23377441

Noninvasive predictors of subdural grid seizure localization in children with nonlesional focal epilepsy.

Giridhar P Kalamangalam1, Elia M Pestana Knight, Shyam Visweswaran, Ajay Gupta.   

Abstract

PURPOSE: Subdural grid evaluation (SDE) in refractory focal epilepsy aims to precisely define the ictal onset zone and map eloquent cortex. In a small but significant proportion of children, SDE shows multifocal or diffuse, rather than focal, seizure onset. Resective epilepsy surgery is denied, or is unsuccessful, in the majority of such patients. The authors investigated whether the noninvasive data could be abstracted to predict subsequent SDE electrographic outcome (focal vs. multifocal/diffuse ictal onset).
METHODS: The authors retrospectively reviewed charts of 66 children with refractory focal epilepsy undergoing SDE at Cleveland Clinic over a 7-year period, studied previously by Pestana Knight et al. A semiquantitative "score" summarizing the localizing value and concordance between selected noninvasive investigations (interictal and ictal EEG; positron emission tomography [PET], and/or single-photon emission computed tomography [SPECT]), as well as Bayesian predictors of individual investigations and their combinations, were adapted from the study of Kalamangalam et al to the subset of patients with nonlesional cranial MRI.
RESULTS: Forty (60.6%) patients had a single MRI brain lesion, 7 (10.6%) had bilateral or diffuse MRI changes, and 19 (28.8%) were nonlesional. Subdural grid evaluation ictal onset was nonfocal in four patients in the first group (10%) and in two patients (28.5%) in the second group. One patient in the third (nonlesional) group was excluded because of incomplete data. In the remainder (n = 18), SDE ictal onset was multifocal or diffuse in 5 (27.8%) and focal in 13 (72.2%). Focality on SDE was positively correlated with higher noninvasive scores in the nonlesional patient group (χ test, P < 0.025). Bayesian predictors in this group were highest for concordance between the interictal and ictal scalp EEG (likelihood ratio = 3.85). Considered separately, interictal and ictal EEG were of equivalent predictive value (likelihood ratio = 2.3 and 2.1, respectively). Metabolic imaging was the least useful modality.
CONCLUSIONS: (1) Diffuse or multifocal ictal onsets on SDE are almost three times as likely in nonlesional patients as in those with a single definite MRI brain lesion. (ii) The noninvasive data of children with nonlesional brain MRI may be summarized by a score that rewards localizing information and intermodality concordance: low-scoring patients are more likely to exhibit diffuse or multifocal ictal onset on subsequent SDE. (iii) Bayesian likelihood ratios predictive of ictal focality on SDE are highly favorable for concordant scalp interictal-ictal EEG combinations. (iv) Decision-theoretic methods of this type may find use in the selection of nonlesional pediatric presurgical candidates offered SDE.

Entities:  

Mesh:

Year:  2013        PMID: 23377441      PMCID: PMC6822165          DOI: 10.1097/WNP.0b013e31827edca4

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  11 in total

1.  Indications and outcome of ictal recording with intracerebral and subdural electrodes in refractory complex partial seizures.

Authors:  T R Henry; D A Ross; L A Schuh; I Drury
Journal:  J Clin Neurophysiol       Date:  1999-09       Impact factor: 2.177

2.  Noninvasive correlates of subdural grid electrographic outcome.

Authors:  Giridhar P Kalamangalam; Harold H Morris; Jayanthi Mani; Deepak K Lachhwani; Shyam Visweswaran; William M Bingaman
Journal:  J Clin Neurophysiol       Date:  2009-10       Impact factor: 2.177

3.  Outcome of no resection after long-term subdural electroencephalography evaluation in children with epilepsy.

Authors:  Elia M Pestana Knight; Tobias Loddenkemper; Deepak Lachhwani; Prakash Kotagal; Elaine Wyllie; William Bingaman; Ajay Gupta
Journal:  J Neurosurg Pediatr       Date:  2011-09       Impact factor: 2.375

Review 4.  Invasive EEG monitoring in children: when, where, and what?

Authors:  P Jayakar
Journal:  J Clin Neurophysiol       Date:  1999-09       Impact factor: 2.177

Review 5.  Current themes in neuroimaging of epilepsy: brain networks, dynamic phenomena, and clinical relevance.

Authors:  Mark Richardson
Journal:  Clin Neurophysiol       Date:  2010-02-24       Impact factor: 3.708

6.  Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome.

Authors:  C Juhász; D C Chugani; O Muzik; A Shah; J Shah; C Watson; A Canady; H T Chugani
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

Review 7.  Temporal lobe epilepsy: when are invasive recordings needed?

Authors:  B Diehl; H O Lüders
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

8.  Use of subdural grids and strip electrodes to identify a seizure focus in children.

Authors:  P D Adelson; P M Black; J R Madsen; U Kramer; M A Rockoff; J J Riviello; S L Helmers; M Mikati; G L Holmes
Journal:  Pediatr Neurosurg       Date:  1995       Impact factor: 1.162

9.  Successful surgery for epilepsy due to early brain lesions despite generalized EEG findings.

Authors:  E Wyllie; D K Lachhwani; A Gupta; A Chirla; G Cosmo; S Worley; P Kotagal; P Ruggieri; W E Bingaman
Journal:  Neurology       Date:  2007-07-24       Impact factor: 9.910

10.  Epilepsy surgery in patients with normal or nonfocal MRI scans: integrative strategies offer long-term seizure relief.

Authors:  Prasanna Jayakar; Catalina Dunoyer; Pat Dean; John Ragheb; Trevor Resnick; Glenn Morrison; Sanjiv Bhatia; Michael Duchowny
Journal:  Epilepsia       Date:  2008-02-07       Impact factor: 5.864

View more
  1 in total

1.  Lateralization of temporal lobe epilepsy by multimodal multinomial hippocampal response-driven models.

Authors:  Mohammad-Reza Nazem-Zadeh; Kost V Elisevich; Jason M Schwalb; Hassan Bagher-Ebadian; Fariborz Mahmoudi; Hamid Soltanian-Zadeh
Journal:  J Neurol Sci       Date:  2014-09-28       Impact factor: 3.181

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.